Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- Procedure: endoscopic full thickness plication
- Registration Number
- NCT01798212
- Lead Sponsor
- Krankenhaus Barmherzige Schwestern Linz
- Brief Summary
A prospective multi center case controlled trial on the clinical feasibility of a new full thickness endoscopic plication device for patients with GERD.
The primary objective of the present trial is to investigate, clinical feasibility of the GERDx™ device, evaluating surgical aspects, quality of life, and symptom sores. Secondary objective of the trail is to evaluate objective data before and after the procedure, using manometry and 24h impedeance measurement
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Written informed consent; ≥ 18 years of age;
GERD documented by 24h ambulatory Multichannel Impedance-pH-Monitoring off antisecretory therapy and/or Gastroscopy by one or more of the following criteria:
- Total Number of Reflux Events ≥ 73/24h;
- DeMeester Score ≥ 14.7;
- Positive Symptom Index - SI ≥ 50% for Symptoms troublesome for the Patient with a Frequency of at least 3/24hrs; Macroendoscopically distinct mucosal breaks.
Patients with known immunological dysfunction (advanced liver disease, HIV, hepatitis C virus infection), drug addiction;
≤ 18 years of age; Pregnancy and lactation; Previous extensive abdominal surgery; Previous esophageal or gastric surgery; Hiatal hernia >2cm; paraesophageal hernia; American Society of Anaesthesiologists physical status classification >II
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description full thickness gastroplication endoscopic full thickness plication -
- Primary Outcome Measures
Name Time Method Quality of Life using the Gastrointestinal Quality of Life Index change from baseline in Quality of Life at 3 months, one year and three years after the intervation
- Secondary Outcome Measures
Name Time Method lower esophageal sphincter pressure using oesophageal manometry change from baseline in lower esophageal sphincter pressure at 3 months, one year and 3 years after the intervantion DeMeester score, number of reflux events using 24h-ph-Impedancemeasurment change from baseline in DeMeester score at 3 months, one year and 3 years after the intervantion
Trial Locations
- Locations (2)
Krankenhaus Zell am See
🇦🇹Zell am See, Austria
Krankenhaus Barmherzige Schwestern
🇦🇹Linz, Austria